PCNA and cancer: The increased expression of G1 cyclins in cancer cells provides them an uncontrolled growth advantage because most of these cells either lack Cdki, harbor nonfunctional Cdki, or Cdki expression is not at a sufficient level to control Cdk-cyclin activity [38], [40].